National Development and Reform Commission Reduces the Price of Seventeen Drugs

Business News Agency December 1 hearing Recently, the National Development and Reform Commission issued a notice and decided to reduce the maximum retail price of some separately-priced drugs such as ceftriaxone, which involves Antibiotics, cardiovascular and cerebrovascular diseases, and other seventeen categories of drugs from December 12. .

The adjusted price is reduced by an average of 19% from the current stipulated price, and is expected to reduce the burden on the people by nearly 2 billion yuan each year. The retail price level of some commonly used drugs has been significantly reduced, and the masses will actually feel the decrease in actual prices. For example, the price of captopril (commercial name: Kaibotong, 12.5mg*20 tablets) produced by Sino-US Shanghai Shiguibao Pharmaceutical Co., Ltd. dropped from 34 yuan to 22.1 yuan, a decrease of 35%; ceftriaxone produced by Roche (Commodity name: Robust, 1g injection) Price dropped from 93.8 yuan to 65.7 yuan, a decrease of 30%.